PSEUDOMONAS AERUGINOSA
Clinical trials for PSEUDOMONAS AERUGINOSA explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled combo aims to fight stubborn lung infections in cystic fibrosis
Disease control CompletedThis study tested an inhaled drug called RSP-1502, which combines the antibiotic tobramycin with a substance called CaEDTA, in 71 people with cystic fibrosis who have chronic Pseudomonas lung infections. The goal was to check safety and find the right dose. Participants received …
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New antibiotic combo shows promise against superbug infections
Disease control CompletedThis study looked at 200 adults with multidrug-resistant Pseudomonas infections who were treated with the antibiotic combination ceftolozane-tazobactam. Researchers tracked how many patients survived at 30 days and while in the hospital, and whether follow-up cultures showed the …
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Temple University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Washing therapy dogs may keep hospital germs away from kids
Disease control CompletedThis study tested whether cleaning therapy dogs with a special disinfectant (chlorhexidine) before hospital visits could reduce the spread of harmful germs to children. The trial involved 45 children aged 3 to 17 who interacted with therapy dogs. Researchers checked if the cleani…
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE4 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Virus cocktail inhaled to fight Drug-Resistant lung infection
Disease control CompletedThis study tested an inhaled mixture of bacteria-killing viruses (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. Participants received either the phage therapy or a placebo by inhalation. The goal was to see if the phages could safely reduce the…
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt superbug in water and people to stop its spread
Knowledge-focused CompletedThis study aimed to create a smart surveillance strategy for carbapenem-resistant Pseudomonas aeruginosa (CRPA), a superbug that causes hard-to-treat infections in hospitals. Researchers collected samples from over 2,100 healthy people, patients, and hospital environments in the …
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC